ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SAR Sareum Holdings Plc

32.00
0.50 (1.59%)
26 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Sareum Holdings Plc LSE:SAR London Ordinary Share GB00BMC3RJ87 ORD GBP 0.0125
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.50 1.59% 32.00 31.00 33.00 32.00 31.50 31.50 146,816 08:39:19
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 0 -3.19M -0.0449 -7.13 22.39M
Sareum Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SAR. The last closing price for Sareum was 31.50p. Over the last year, Sareum shares have traded in a share price range of 10.20p to 105.50p.

Sareum currently has 71,069,416 shares in issue. The market capitalisation of Sareum is £22.39 million. Sareum has a price to earnings ratio (PE ratio) of -7.13.

Sareum Share Discussion Threads

Showing 18476 to 18497 of 18525 messages
Chat Pages: 741  740  739  738  737  736  735  734  733  732  731  730  Older
DateSubjectAuthorDiscuss
24/7/2024
14:55
The post below (from LSE) clearly not in reality PMSL 🤣 👇 My answers below his:

Leggster
Posts: 339
Price: 33.00
No Opinion
News FlowToday 12:58
Despite the attempts to misdirect by some, we can expect news and it will arrive in due course

- topline safety results being shared

Yep we know, Safety data is one thing. We still don't know if 1801 works! 🤦🏻

- Way forward for 1801

Perhaps 1801 will go backwards in the
next Phase of the clinical trial?

- 737 update

Are you kidding me. 737 is all if, buts or maybes - absolutely no idea if it works. Currently NO revenue. GSK didn't want it.

- possible license deal for 1801 (possibly including 1802)

No hint at all of licensing or take over deals. I'm sorry, but you're clearly living in cloud cuckoo land and are over excited - there ARE NO DEALS!

- Possible takeover

See answer above

- future plans for 1802

There're no future plans at present!

- Possible VC stake

😂

- New CEO

And?

GLA

Your going to need it!!

peaceandlove
24/7/2024
14:55
Look at that share price fall..

Time to short some more...

wolfofwallstreets
24/7/2024
12:26
Great post on lse..


I have to agree with you FunnyGuy, SOG spends day and night writing reams of stuff that frankly I can't be bothered to read. This is normally followed by his mate Celtic backing up everything he's written and calling anyone else with an alternative opinion a tw*t. If only I had a penny every time I read on here "news soon".

wolfofwallstreets
24/7/2024
07:35
Another day goes by and no news. The reason there's no news is because there isn't any. As per usual, the happy clappers use their imagination, put 2+2 together and get 5! There're no license or takeover deals on the horizon IMO. If there was they'd need to be disclosed. Assuming the results are satisfactory, my hunch is they'll announce a placing and it'll go on and on..... I said many times Clinical trials are very expensive. There is no guarantee Sareum will succeed and with 90% of clinical trials failing the odds are against them. So many unanswered questions with this company.
peaceandlove
23/7/2024
19:59
Any imaginary takeovers happen today?!

Or imaginary licence deals?!

Or "deals in our sector..."

Bunch of ramping clowns...

Rns soon for more cash....

wolfofwallstreets
23/7/2024
16:16
Honestjon is just sadoldfart from lse...

Ramping clown..

wolfofwallstreets
23/7/2024
15:59
Not sure what happy clsppy is?
Possibly because you can’t coordinate a clap?
Clown

honestjon
23/7/2024
15:13
Hahaha...

"Sareum will triumph this year"..

(c) 2020, 2021, 2022, 2023, 2024

Away you go, you happy clsppy ramper..

wolfofwallstreets
23/7/2024
12:01
Sareum will triumph this year.
honestjon
23/7/2024
09:05
Sareum will collapse this year...
wolfofwallstreets
22/7/2024
22:21
No wolf its in the rns that GSK are holders of SRA737
I can't unfortunately say that's you are wrong .but you are
Lse are digging their own grave if they ignore my posts
.shame...but interesting with strategic reasons..I hold more than them..even Shepherd...nothing by association with a similar name involved in trust funds...I got contacted by an lse poster...but hold my own.

criticalthinker1
22/7/2024
22:01
"Ground breaking info.."

So full of it..

You post copy and paste garbage that nobody reads...

You're a fool...

Sareum.will die by year end...

wolfofwallstreets
22/7/2024
21:53
Criticalstinker...do you have dementia?!

You're the genius who said 737 was being returned so gsk could launch a takeover...

You can't even remember the garbage you come out with...

Let me have a rummage...

wolfofwallstreets
22/7/2024
21:05
The only possible concern I have wolf is my posts get no upticks...so despite my posts being on point I wonder if certain posters on lse are working this company for their own benefit...food for thought...shame if its true...would make sense given the ground breaking info I've put forward...
That would make pcs sog indirect rampers...because they say multiple times about advfn posters but fail to recognise my input...hmmmmmmm

criticalthinker1
22/7/2024
20:59
Interesting you keep talking about takeover as opposed to onlicense...personally I don't want a takeover as it would be a Sierra Oncology scenario...but that's your modus operandi...you never talk positively about Sareum...but your post is noted.
criticalthinker1
22/7/2024
20:40
Criticalstinker...

Great post...didn't read a word...

You're dreaming your life away...

When's the takeover...

wolfofwallstreets
22/7/2024
19:21
Not sure billions of shares, unless multiple buying and selling....however, it's worth remembering that the introducers have warrants outstanding as do some of HNWIS..but not enough to make the share count...billions...maybe spellchecker played up...
But food for thought

In late 2021, Sierra had indicated revived interest in developing SRA737 as a potential combination therapy (in both haematological malignancies and solid tumours) following its in-licensing of the BET inhibitor AZD5153 (now known as SRA515) from AstraZeneca (August 2021). As per our understanding, Sierra was in the process of finalising trial designs for the three possible studies assessing SRA737 as a combination treatment, before receiving the offer from GSK.

Now I've proven that SRA737 has continued in its progress...I feel the newly shuffled board might address this.
Atleast they surely have to.
Just wonder if Blenrep got a helping hand...and not forgetting that AZ got involved with AZD 5153...aka SRA515...dexamethasone....pomalidomide.
So my muse. ..

GSK have now a carte blanche and have the means to undertake a clean break with their pharma side since Haleon now independent...but would love to bring a company into its fold that have multiple patents in the USA and China and Europe...I believe pending...with THE ipr that is required...imo...Will GSK and AZ have an affiliation in progress...
All best Steadydanny
And yes the investment into cytokine storms and cytotoxicity is imo of very a noteable requirement...citizen puts it politely in his post...maybe he researched my posts?
Nevertheless, we can all have our opinions snd those hopefully backed by research...we can always DREAMM-8...

criticalthinker1
22/7/2024
18:48
How do you mean??
wolfofwallstreets
22/7/2024
17:28
In few days billions of the share going to exchange
hamidmontana
22/7/2024
09:33
Sadoldtart is so stupid that he still calls this BB "ADVN"...

Utter moron..

"Good morning c79..great post from you as usual"..

As you're just another subservient agreeable ramping fool who agrees with me ...

wolfofwallstreets
22/7/2024
08:10
Sadoldtart being rinsed again on lse...

Utter ramping moron..

wolfofwallstreets
21/7/2024
20:34
Wolf, take note of Bobblers post on LSE.
The average retail price for Sotyktu is $8,348.71 per 30, 6MG Tablet.

Looks like those tyk2’s do have a value. No guarantee Sar have it cracked, but certainly looks like a decent gamble.

honestjon
Chat Pages: 741  740  739  738  737  736  735  734  733  732  731  730  Older

Your Recent History

Delayed Upgrade Clock